| USB |
Report |
Adjusted diluted EPS |
BEAT |
pred ~$1.30 vs. cons $1.28 |
MEDIUM |
| USB |
Report |
Total net revenue |
IN-LINE |
pred ~$7.67B vs. cons $7.61B |
MEDIUM |
| USB |
Report |
Taxable-equivalent net interest income |
IN-LINE |
pred ~$4.36B vs. cons $4.34B |
HIGH |
| USB |
Guide |
Total net revenue growth |
UNCHANGED |
guide ~7.0% vs. cons 7.0% (FY2026) |
MEDIUM |
| USB |
Guide |
Positive operating leverage |
LOWER |
guide ~200 bps vs. cons 220 bps (FY2026) |
MEDIUM |
| USB |
Guide |
Taxable-equivalent net interest income |
BETTER |
guide ~$4.44B vs. cons $4.42B (Q3 2026) |
LOW |
| USB |
Return |
Day-1 residual (stock − beta × S&P 500) |
+0.8% |
— |
LOW |
| USB |
Return |
5-day cumulative residual |
+0.3% (FADE) |
The Q2 EPS beat is largely pre-signaled and only ~2 cents versus consensus; FY2026 operating-leverage guidance of ~200 bps versus consensus 220 bps limits out-period estimate increases, causing the day-1 residual of +0.8% to fade toward a +0.3% five-day residual. |
LOW |